EFL021 - Metabolic Effects of a Dual GIP and GLP-1 RA
Join host Chase Hendrickson, MD, from Vanderbilt Unviersity Medical Center, as he discusses a recent article in The Journal of Clinical Endocrinology & Metabolism with Ashok Balasubramanyam, MD, from Baylor College of Medicine and invited topical expert Steven Bain, MD, from Swansea University. The article is from the February 2022 edition of JCEM: “Effects of Tirzepatide, a Dual GIP and GLP-1 RA, on Lipid and Metabolite Profiles in Subjects with T2D.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/en...
▶︎
GLP 1 Deep Dive with Dr. Jeff Bland
▶︎
GLP-1 Agonists: Wonder Drugs of the 21st Century?
▶︎
EFL069 - The Gut Microbiome in Type 1 Diabetes and Obesity
▶︎
Dual and Triple Co-agonists: From Discovery to Best-In-Class | President Matthias Tschöp
▶︎
ENP110: Hypercortisolism and T2D
▶︎
I’m a Pathologist: The "Biological Cost" of Ozempic and Mounjaro.
▶︎
How do GLP-1 Agonists Work? (EASY Pharmacology)
▶︎
Beyond the Needle: The Future of GLP-1 Pills and Other Emerging Obesity Treatments
▶︎
Defining the Product: How Marketers Can Break the Higher Ed Sea of Sameness
▶︎
How Do Ozempic, Mounjaro & Other GPL-1 Agonists Work? | Dr. Zachary Knight & Dr. Andrew Huberman
▶︎
Navigating GLP-1 agonists | DoM Grand Rounds | 17 January 2024
▶︎
Fatty Liver Expert: The Toxic Ingredient Silently Filling Your Liver With Fat - Dr David Unwin
▶︎
EFL022 - Care Gaps in Primary Hyperparathyroidism
▶︎
Cardiovascular Benefits of GLP-1 RAs
▶︎
Andrew Huberman: Peptides, Sleep Tech, and the End of Obesity
▶︎
Interpreting the Data with Tirzepatide
▶︎
Tirzepatide (GIP/GLP-1 Agonists) for Diabetes: Pharmacology Made Easy
▶︎
Dr. Ben Bikman - 'GLP-1 Drugs: Consequences and Considerations'
▶︎
42: What is GLP-1, What Does It Do, and Where Does It Come From with Dr. Ben Bikman
▶︎